Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

In another example of the volatility facing developers of obesity drugs, Veru saw its share price cut nearly in half – despite reporting ostensibly positive data for a drug candidate.

Oppenheimer analyst Leland Gershell reiterated a Buy rating on Argenx Se (ARGX – Research Report) today and set a price target of $704.00. The ...

The breast cancer market has experienced robust growth, fueled by increased awareness and early detection efforts. Advances in diagnostic and treatme ...

After hours: 7:31:09 p.m. EST ...

After hours: February 28 at 7:37:45 PM EST Loading Chart for MNMD ...

After hours: February 28 at 5:15:46 PM EST Loading Chart for INSG ...

After hours: February 28 at 7:37:45 p.m. EST ...